BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34174286)

  • 1. Von Hippel-Lindau (VHL) small-molecule inhibitor binding increases stability and intracellular levels of VHL protein.
    Frost J; Rocha S; Ciulli A
    J Biol Chem; 2021 Aug; 297(2):100910. PubMed ID: 34174286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298).
    Soares P; Gadd MS; Frost J; Galdeano C; Ellis L; Epemolu O; Rocha S; Read KD; Ciulli A
    J Med Chem; 2018 Jan; 61(2):599-618. PubMed ID: 28853884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition.
    Frost J; Galdeano C; Soares P; Gadd MS; Grzes KM; Ellis L; Epemolu O; Shimamura S; Bantscheff M; Grandi P; Read KD; Cantrell DA; Rocha S; Ciulli A
    Nat Commun; 2016 Nov; 7():13312. PubMed ID: 27811928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
    Maynard MA; Ohh M
    Am J Nephrol; 2004; 24(1):1-13. PubMed ID: 14654728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein.
    Groulx I; Lee S
    Mol Cell Biol; 2002 Aug; 22(15):5319-36. PubMed ID: 12101228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions.
    Jung YS; Lee SJ; Yoon MH; Ha NC; Park BJ
    Cell Cycle; 2012 Dec; 11(23):4462-73. PubMed ID: 23159849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Hippel-Lindau (VHL) Protein Antagonist VH298 Improves Wound Healing in Streptozotocin-Induced Hyperglycaemic Rats by Activating Hypoxia-Inducible Factor- (HIF-) 1 Signalling.
    Qiu S; Jia Y; Sun Y; Han P; Xu J; Wen G; Chai Y
    J Diabetes Res; 2019; 2019():1897174. PubMed ID: 30911550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Hippel-Lindau (VHL) protein antagonist, VH298, promotes functional activities of tendon-derived stem cells and accelerates healing of entheses in rats by inhibiting ubiquitination of hydroxy-HIF-1α.
    Qiu S; Jia Y; Tang J; Liu X; Hu H; Wu T; Chai Y
    Biochem Biophys Res Commun; 2018 Nov; 505(4):1063-1069. PubMed ID: 30314704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interaction.
    Buckley DL; Van Molle I; Gareiss PC; Tae HS; Michel J; Noblin DJ; Jorgensen WL; Ciulli A; Crews CM
    J Am Chem Soc; 2012 Mar; 134(10):4465-8. PubMed ID: 22369643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity.
    Lewis MD; Roberts BJ
    Oncogene; 2004 Mar; 23(13):2315-23. PubMed ID: 14691445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient strategy for digging protein-protein interactions for rational drug design - A case study with HIF-1α/VHL.
    Xue X; Kang JB; Yang X; Li N; Chang L; Ji J; Meng XK; Zhang HQ; Zhong Y; Yu SP; Wu WY; Wang XL; Li NG; Sun SL
    Eur J Med Chem; 2022 Jan; 227():113871. PubMed ID: 34638033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of VHL by VH298 Accelerates Pexophagy by Activation of HIF-1α in HeLa Cells.
    Kim YH; Park NY; Jo DS; Bae JE; Kim JB; Park K; Jeong K; Kim P; Yeom E; Cho DH
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α Hydroxyprolines Modulate Oxygen-Dependent Protein Stability Via Single VHL Interface With Comparable Effect on Ubiquitination Rate.
    He W; Batty-Stuart S; Lee JE; Ohh M
    J Mol Biol; 2021 Nov; 433(22):167244. PubMed ID: 34537235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
    Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
    BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
    Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
    Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ensemble-based virtual screening in discovering potent inhibitors targeting Von Hippel-Lindau (VHL) E3 ubiquitin ligase.
    Liu Y; Lei Y; Guo S; Zuo Z
    Life Sci; 2020 Dec; 262():118495. PubMed ID: 32987061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VHL mutations linked to type 2C von Hippel-Lindau disease cause extensive structural perturbations in pVHL.
    Knauth K; Cartwright E; Freund S; Bycroft M; Buchberger A
    J Biol Chem; 2009 Apr; 284(16):10514-22. PubMed ID: 19228690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.
    Pugh CW; Ratcliffe PJ
    Semin Cancer Biol; 2003 Feb; 13(1):83-9. PubMed ID: 12507560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
    Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
    BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.